Circassia Group (CIR) Share Price, News & Analysis

Company Overview

Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 34 to 34
• 52-Week Range: N/A
• Volume: 4,513 shs
• Average Volume: 773,465 shs
• Market Capitalization: £142.66 million
• P/E Ratio: 3,400.00
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CIR Stock Analysis - Frequently Asked Questions

How were Circassia Group's earnings last quarter?

Circassia Group Plc (LON:CIR) issued its quarterly earnings data on Thursday, September, 17th. The company reported ($3.00) EPS for the quarter.

How do I buy shares of Circassia Group?

Shares of CIR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Circassia Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Circassia Group investors own include EnQuest (ENQ), boohoo group (BHOOY), Cummins (CMI), Tullow Oil (TLW), Ascential (ASCL), FutureFuel (FF) and H&T Group (HAT).

Company Calendar

• Last Earnings: 9/17/2020
• Today: 5/10/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:CIR
• CIK: N/A
• Web: www.circassia.co.uk
• Phone: 44 1865 405 560
• Fax: N/A
• Employees: 111
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 3,400.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.95
• Current Ratio: 1.83
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: £27.90 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 11.33
• Book Value: GBX 16 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 419,578,000
• Free Float: N/A
• Market Cap: £142.66 million
• Optionable: Not Optionable
• Beta: N/A